Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
We have rich experience of offering CRO and CDMO services throughout the peptide drug development process for IND, NDA & ANDA projects, provide safe and efficient guidance from development to commercial production.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
The purity of Semaglutide is critical to both its efficacy and safety. The main difference between Semaglutide API with 99% purity and 98% purity lies in the amount of active ingredient present and the potential level of impurities in the substance. The higher the purity, the greater the proporti...
On the journey of diabetes treatment, Tirzepatide shines like a rising star, radiating with unique brilliance. It focuses on the vast and complex landscape of type 2 diabetes, offering patients a brand-new therapeutic strategy. Through its precise metabolic regulation, Tirzepatide works deep with...
Retatrutide is an emerging multi-receptor agonist, mainly used to treat obesity and metabolic diseases. It can simultaneously activate three incretin receptors, including GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon receptor. This multiple mecha...
What to do if you don’t lose weight on a GLP-1 medication? Importantly, patience is essential when taking a GLP-1 medication like semaglutide. Ideally, it takes at least 12 weeks to see results. However, if you don’t see weight loss by then or have concerns, here are some options to consider. Tal...
Cardiovascular disease is one of the leading global health threats, and the emergence of Tirzepatide brings new hope for the prevention and treatment of cardiovascular conditions. This medication works by activating both GIP and GLP-1 receptors, not only effectively cont...